This may be acceptable given that TNBC is considered a Trop-2 protein-positive cancer as reported by Goldenberg et al. (~85% positivity rate) [1,37] and 73% in the study of Ambrogi et al. [38]. This evidence concerns the gene TACSTD2 and cancer.